CTV National News: Canadians turn to AI for medical diagnoses
As many Canadians don't have family doctors, some are turning to AI however the technology can be inaccurate at times. John Vennavally-Rao reports.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
19 minutes ago
- Globe and Mail
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Our mission remains steadfast: delivering clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen has become a recognized name for its business philosophy of social responsibility, patient affordability and cost efficiency. In under five years, we validated our proprietary ExacTcell™ platform, completed successful proof-of-concept clinical trial of the platforms first product, established drug discovery R&D center — currently in the process of establishing our own GMP cell manufacturing facility, expanded corporate infrastructure, built a robust intellectual property portfolio, and established one of the pioneering AI initiatives in the industry — assets of significant value, while maintaining 74% insider equity ownership. With the successful launch of our proprietary AI-driven PredicTcell™ platform, we've significantly enhanced target discovery efficiency. Strategic partnerships with global technology leaders, such as Microsoft and Databricks, have accelerated our progress. Recent patent filings further secure our intellectual property in AI-driven predictive modeling, positioning us at the forefront of innovation. Importantly, Tevogen Bio is well capitalized, having access to necessary funding we may require to fully execute our current growth strategy, including the accelerated development of While the sector faces significant challenges, our company continues to grow, underscoring the foundational strength of our company. We deeply appreciate your continued support as we work toward our vision of transforming healthcare through democratizing access. It feels good to be part of this growth story and am grateful to my colleagues at Tevogen for their exceptional expertise, dedication, and, above all, their compassion for others. Sincerely, Ryan Saadi, MD, MPH Founder and CEO, Tevogen Bio Recent Announcements Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility Builds Alpha Version of PredicTcell Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation Forward-Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts
CTV News
19 minutes ago
- CTV News
WRH highlighting ‘critical need' to fill diagnostic imaging jobs and get more students into the field
Officials at Windsor Regional Hospital are working to highlight the critical need for students to consider diagnostic imaging as a future career while actively recruiting to fill those positions within the hospital. External Recruitment Coordinator Erin Hodgson said X-ray technicians, CT scan technicians, and nuclear medicine technologists are the positions the hospital has the most difficult time finding top talent for. As part of a recruitment effort, the hospital is offering a $25,000 signing bonus for those in-demand positions, while there is also help available with relocation costs for anyone moving from outside the region. One reason cited for the difficulty in filling those positions is that anyone locally pursuing these fields needs to leave the area to receive their two to three years of college education, with only a handful of schools offering programs in those fields. Hodgson said the nuclear medicine technologist position is challenging to fill because there are only five schools in Canada, with just one in Ontario, that offer that program. 'The need goes up because you have a workforce that's retiring out of these careers, but the number of students graduating out of these education streams, specifically for nuclear medicine tech, is not enough to meet the demand for the number of people who are leaving this role,' she said. The salary for an X-ray, CT or nuclear medicine technologist starts at $36 to $37 per hour. Hodgson said one of the big problems they're trying to address is a lack of knowledge that these career paths exist. 'I've been working really closely with the Greater Essex County District School Board to develop programs with the Experiential Learning Team and their SHSM [Specialist High Skills Major] Team to get into the high schools and talk to students about careers exactly like this that are in healthcare, outside the scope of nursing and medicine that everybody knows about,' she said. Hodgson said the demand for nuclear medicine is critical in Windsor-Essex, Ontario, and across Canada. 'We need the bodies; we need the people going into these education streams that they may not even be aware of. I think the initiative, especially put forth by Windsor Regional Hospital for recruitment and also education in the community, is working very hard every day,' she said. The hospital is also launching a new job shadow program for anyone 16 years and older, and the diagnostic imaging department is an active part of the program. Click here to find a link to register for the program. - Written by Rusty Thomson/AM800 News.
CTV News
19 minutes ago
- CTV News
First at Five: Emancipation Day
Atlantic Watch AAt Province House in N.S., dignitaries raised the African- Pan flag to commemorate Emancipation Day.
